Brain Cancer Biomarker Enables Targeted Treatment

News   Oct 17, 2017 | Original Story from the Icahn School of Medicine at Mount Sinai

 
Biomarker for Glioblastoma Predicts Clinical Course and Sensitivity to Treatment
 
 
 

RELATED ARTICLES

Lonza Expands Encapsulation and HPAPI Capabilities in North America

News

Expanding our capabilities into commercial-scale encapsulation responds to our customers' desire to maintain programs at the Tampa, FL (USA) site from clinical development to commercialization.

READ MORE

Cancer Pioneer Employs Physics to Approach Cancer

News

In the cover article of Oncotarget, February 20, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.

READ MORE

Protein Analysis Gives Insight into Parkinson's

News

A study has characterized levels of pathological proteins from throughout the bodies of Parkinson's Disease patients, revealing some surprising findings.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE